Ch, Iftikhar Ali
Nasir, Khurram
Chaudhry, Azhar
Wu, Pei-Tzu
Siddique, Muhammad
Ullah, Raja
Tahirkheli, Mashal
Qadar, Abdul
Weitzel, Hunter
Jamal, Rahat
Tahirkheli, Naeem
Article History
Received: 8 November 2024
Accepted: 6 April 2025
First Online: 16 April 2025
Declarations
:
: Dr Khurram Nasir MD: CONSULTING FEES/HONORARIA: Amgen Inc.(SIGNIFICANT), Esperion(MODEST), Novartis Corporation(MODEST), Novo Nordisk Inc.(SIGNIFICANT) SPEAKER'S BUREAU: Amgen Inc.(MODEST). All other authors: None.
: This ethics statement affirms that the research adhered to the highest ethical standards and guidelines established by regulatory bodies. Informed consent was obtained from the participants, confidentiality and privacy of participant information were maintained, conflicts of interest are denied, high morals were upheld, data integrity and transparency were ensured, authorship criteria were outlined, and contributions were acknowledged appropriately.